2004 immunization schedule for January to June 2004
RSV Roundtable: What clinicians are witnessing in terms of RSV incidence
Last year’s historic RSV season left many wondering if this was going to become a recurring trend. Physicians weigh in on what they are seeing at their institutions in terms of infection rates.
What's going on with polio, monkeypox, and COVID-19
The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?
CDC recommends nirsevimab be prioritized for highest-risk infants amid limited availability
The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
What Omicron could mean for the pandemic
Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.
Navigating a complex case of pediatric COVID-19 with immunomodulatory therapies
Eculizumab and anakinra should be considered in critically ill patients with severe infections that require immunomodulating therapies for life-threatening dysregulation, according to a poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition.
AAP National Conference & Exhibition: what you can expect
A sneak peek at some of the most exciting sessions at this year's American Academy of Pediatrics national conference.
2 Clarke Drive Cranbury, NJ 08512